Skip to main content
. 2021 Jul 16;2021:6108999. doi: 10.1155/2021/6108999

Figure 6.

Figure 6

PCA prevents RANKL-induced NF-κB activation. (a) Western blots showing the levels of p-p65 and p65. (b) The protein levels were compared with those in the RANKL group. P < 0.01 and #P < 0.05 compared with the group treated with RANKL alone.